Watanabe M - Search Results

1

Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.

Tazawa R, Hamano E, Arai T, Ohta H, Ishimoto O, Uchida K, Watanabe M, Saito J, Takeshita M, Hirabayashi Y, Ishige I, Eishi Y, Hagiwara K, Ebina M, Inoue Y, Nakata K, Nukiwa T. Tazawa R, et al. Among authors: watanabe m. Am J Respir Crit Care Med. 2005 May 15;171(10):1142-9. doi: 10.1164/rccm.200406-716OC. Epub 2005 Feb 25. Am J Respir Crit Care Med. 2005. PMID: 15735059 Clinical Trial.

2

Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung?

Nakata K, Kanazawa H, Watanabe M. Nakata K, et al. Among authors: watanabe m. Respirology. 2006 Jan;11 Suppl:S65-9. doi: 10.1111/j.1440-1843.2006.00812.x. Respirology. 2006. PMID: 16423275

3

A cell-free assay to estimate the neutralizing capacity of granulocyte-macrophage colony-stimulating factor autoantibodies.

Urano S, Kaneko C, Nei T, Motoi N, Tazawa R, Watanabe M, Tomita M, Adachi T, Kanazawa H, Nakata K. Urano S, et al. Among authors: watanabe m. J Immunol Methods. 2010 Aug 31;360(1-2):141-8. doi: 10.1016/j.jim.2010.07.001. Epub 2010 Jul 16. J Immunol Methods. 2010. PMID: 20621102

4

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.

Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, Stevens CA, Beck DC, Denson LA, Carey BC, Keicho N, Krischer JP, Yamada Y, Trapnell BC. Uchida K, et al. Among authors: watanabe m. Blood. 2009 Mar 12;113(11):2547-56. doi: 10.1182/blood-2009-05-155689. Blood. 2009. PMID: 19282464 Free PMC article.

5

High avidity cytokine autoantibodies in health and disease: pathogenesis and mechanisms.

Watanabe M, Uchida K, Nakagaki K, Trapnell BC, Nakata K. Watanabe M, et al. Cytokine Growth Factor Rev. 2010 Aug;21(4):263-73. doi: 10.1016/j.cytogfr.2010.03.003. Epub 2010 Apr 22. Cytokine Growth Factor Rev. 2010. PMID: 20417147 Review.

6

A cell free assay system estimating the neutralizing capacity of GM-CSF antibody using recombinant soluble GM-CSF receptor.

Urano S, Tazawa R, Nei T, Motoi N, Watanabe M, Igarashi T, Tomita M, Nakata K. Urano S, et al. Among authors: watanabe m. J Vis Exp. 2011 Jun 27;(52):2742. doi: 10.3791/2742. J Vis Exp. 2011. PMID: 21730949 Free PMC article.

7

Anti-cytokine autoantibodies are ubiquitous in healthy individuals.

Watanabe M, Uchida K, Nakagaki K, Kanazawa H, Trapnell BC, Hoshino Y, Kagamu H, Yoshizawa H, Keicho N, Goto H, Nakata K. Watanabe M, et al. FEBS Lett. 2007 May 15;581(10):2017-21. doi: 10.1016/j.febslet.2007.04.029. Epub 2007 Apr 24. FEBS Lett. 2007. PMID: 17470370 Free article.

8

[pulmonary alveolar proteinosis and anti-GM-CSF antibody].

Watanabe M, Nakata K. Watanabe M, et al. Nihon Naika Gakkai Zasshi. 2006 Jun 10;95(6):1042-7. doi: 10.2169/naika.95.1042. Nihon Naika Gakkai Zasshi. 2006. PMID: 16846053 Review. Japanese. No abstract available.

9

[Physiopathology and treatment of pulmonary alveolar proteinosis].

Watanabe M, Nakata K. Watanabe M, et al. Nihon Naika Gakkai Zasshi. 2005 Apr 10;94(4):763-8. doi: 10.2169/naika.94.763. Nihon Naika Gakkai Zasshi. 2005. PMID: 15865008 Review. Japanese. No abstract available.

10

[Anti-GM-CSF autoantibodies (GM-CSF autoantibodies)].

Watanabe M. Watanabe M. Nihon Rinsho. 2010 Jun;68 Suppl 6:684-6. Nihon Rinsho. 2010. PMID: 20942163 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,855 results

Search Page